US public health genomics budget slashed

16 February 2011

Ron Zimmern, whilst appreciating the need for restrictions in public funding in the US as elsewhere in the world, has criticised the scale of the OPHG budget reduction (see commentary), suggesting that the CDC has failed to comprehend the strategic importance of genomic science for the health of individuals and populations’ and of the ongoing need to build infrastructure to allow the rapid translation of genomic innovations into health services.

More from us

Genomics and policy news